Logo image of DIDI

DiDi Global Inc (DIDI) Stock Fundamental Analysis

NYSE:DIDI - New York Stock Exchange, Inc. - US23292E1082 - ADR

2.29  -0.07 (-2.97%)

After market: 2.32 +0.03 (+1.31%)

Fundamental Rating

2

DIDI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 39 industry peers in the Ground Transportation industry. DIDI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, DIDI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DIDI has reported negative net income.
DIDI Yearly Net Income VS EBIT VS OCF VS FCFDIDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -10B -20B -30B -40B

1.2 Ratios

Industry RankSector Rank
ROA -64.39%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DIDI Yearly ROA, ROE, ROICDIDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 -10 -20 -30 -40

1.3 Margins

Industry RankSector Rank
OM -30.98%
PM (TTM) -32.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DIDI Yearly Profit, Operating, Gross MarginsDIDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, DIDI has less shares outstanding
Compared to 1 year ago, DIDI has an improved debt to assets ratio.
DIDI Yearly Shares OutstandingDIDI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 1B 2B 3B 4B
DIDI Yearly Total Debt VS Total AssetsDIDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 50B 100B 150B

2.2 Solvency

DIDI has an Altman-Z score of 0.26. This is a bad value and indicates that DIDI is not financially healthy and even has some risk of bankruptcy.
DIDI has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACCN/A
DIDI Yearly LT Debt VS Equity VS FCFDIDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 50B 100B

2.3 Liquidity

A Current Ratio of 2.82 indicates that DIDI has no problem at all paying its short term obligations.
DIDI has a Quick Ratio of 2.81. This indicates that DIDI is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 2.81
DIDI Yearly Current Assets VS Current LiabilitesDIDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 20B 40B 60B

More info and screens

4

3. Growth

3.1 Past

DIDI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -749.99%.
Looking at the last year, DIDI shows a very strong growth in Revenue. The Revenue has grown by 22.64%.
The Revenue has been growing by 8.71% on average over the past years. This is quite good.
EPS 1Y (TTM)-749.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%238.42%
Revenue 1Y (TTM)22.64%
Revenue growth 3Y8.71%
Revenue growth 5YN/A
Sales Q2Q%105.95%

3.2 Future

The Earnings Per Share is expected to grow by 15.00% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.29% on average over the next years.
EPS Next Y93.89%
EPS Next 2Y41.42%
EPS Next 3Y26.21%
EPS Next 5Y15%
Revenue Next Year-24.34%
Revenue Next 2Y-3.43%
Revenue Next 3Y0.71%
Revenue Next 5Y6.29%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DIDI Yearly Revenue VS EstimatesDIDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50B 100B 150B 200B 250B
DIDI Yearly EPS VS EstimatesDIDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DIDI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DIDI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DIDI Price Earnings VS Forward Price EarningsDIDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.3
DIDI Per share dataDIDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

DIDI's earnings are expected to grow with 26.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y26.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DIDI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DiDi Global Inc

NYSE:DIDI (6/10/2022, 8:17:19 PM)

After market: 2.32 +0.03 (+1.31%)

2.29

-0.07 (-2.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)04-16 2022-04-16/bmo
Earnings (Next)06-28 2022-06-28/bmo
Inst Owners0.06%
Inst Owner Change-99.73%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.12B
Analysts85.71
Price Target4.79 (109.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB N/A
EV/EBITDA -0.3
EPS(TTM)-4.34
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.43
BVpS3.44
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -30.98%
PM (TTM) -32.1%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover2.01
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.82
Quick Ratio 2.81
Altman-Z 0.26
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-749.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%238.42%
EPS Next Y93.89%
EPS Next 2Y41.42%
EPS Next 3Y26.21%
EPS Next 5Y15%
Revenue 1Y (TTM)22.64%
Revenue growth 3Y8.71%
Revenue growth 5YN/A
Sales Q2Q%105.95%
Revenue Next Year-24.34%
Revenue Next 2Y-3.43%
Revenue Next 3Y0.71%
Revenue Next 5Y6.29%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A